Protamine-Induced Hypotension and Pulmonary Arterial Hypertension

ABSTRACT

Protamine is a routinely used safe antidote for heparin reversal in cardiovascular surgeries. Protamine was first introduced to prolong the action of insulin preparations. As protamine interacts with platelets and fibrinogen and has an anticoagulant effect of its own, minimal amount is given to neutralize heparin present in plasma. Although infrequent, protamine is associated with serious adverse drug reactions (ADRs), especially in patients with previous history of protamine hypersensitivity. Here, we report a case of protamine-induced pulmonary arterial hypertension and peripheral vascular collapse in a 60-year-old diabetic male patient who had undergone on-pump coronary artery bypass grafting in a tertiary care center. This was a definite, nonpreventable, severe ADR as per causality, preventability, and severity assessment scale. This patient had no previous history of protamine hypersensitivity and was not on any insulin preparations. Despite precise timely treatment and other resuscitative measures, the patient expired subsequent to these ADRs. This case report throws light on the grave requirement in urgent evolvement of pharmacogenetic and pharmacokinetic tools to detect patients who are at risk of precipitating these ADRs and thus to take precautions to prevent them.

KEYWORDS

• Adverse drug reactions
• heparin reversal
• on-pump coronary artery bypass grafting

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/jpp.JPP_157_20Copy

RELATED ARTICLES

Matched on volume, issue, section and article type within J Pharmacol. Pharmacother..

• Article · VOLUME 12, ISSUE 2Monday Blues – Rare Cause of Hypoglycemia in a Child with LeukemiaGowshika Krishnakumar, Dhaarani Jayaraman, Dhivyalakshmi Jeevarathnam, Peter Prasanth Kumar Kommu, Julius Xavier Scott · pp. 100–101Case ReportSame type: ArticleVolume 12
• Article · VOLUME 12, ISSUE 2A Survival Case of Premature Infant with Hepatoblastoma (Fetal Pattern) along with Other Serious Comorbidities and Surgical InterventionsMohammed Fardan, A. Priya Shiva, Aswathy M. Shaji, K. Arun Chander Yadav · pp. 102–105Case ReportSame type: ArticleVolume 12
• Article · VOLUME 12, ISSUE 4Ceftriaxone-Induced Thrombocytopenia in a Patient with Bacterial MeningoencephalitisAnjaly A. Kumar, Vani Vijay, M. Arya, P. K. Vasant, Subhash Chandra, Abhishek C. Menon · pp. 175–176Case ReportSame type: ArticleVolume 12
• Article · VOLUME 12, ISSUE 3Anaphylactic Reaction Following Injection Cefotaxime SodiumBharat Satish Krishnan, Kavita Motilalji Jaiswal, Sujata Dudhgaonkar, Latesh B. Raghute · pp. 137–139Case ReportSame type: ArticleVolume 12